Socket augmentation using a commercial collagen-based product--an animal study in pigs

Current research in bone regeneration focuses on comparing synthetic and xenogenic materials for socket augmentation. Established methods use xenogenic bone grafts, which have shown effectiveness in promoting bone formation. However, the long-term effects of these materials on bone structure remain unclear. Recent studies suggest that xenogenic grafts may not fully mimic natural bone regeneration. This gap motivated the exploration of collagen-based alternatives. No prior work had resolved whether pure collagen could match bone density and structure of natural regeneration. Understanding material effects on bone texture is crucial for implant success. Prior research has shown xenogenic grafts can support osseous healing but may alter bone texture. This uncertainty drove the need for comparative studies on collagen-based augmentation.

This study aimed to evaluate the osteogenic potential of a collagen cone and membrane combination compared to a xenogenic graft in a pig model. The specific problem addressed was whether pure collagen could reduce bone resorption while maintaining natural bone structure. Motivation came from the need for biocompatible materials that avoid foreign body reactions. The study tested if collagen-based augmentation could match xenogenic grafts in promoting bone formation. It also sought to compare the resulting bone texture to natural regeneration. The goal was to determine if collagen-based products could be a viable alternative to xenogenic materials. Researchers focused on measuring bone atrophy and tissue composition in treated and untreated alveoli. The study aimed to provide evidence for collagen's role in socket augmentation.

The study used a porcine model to compare bone regeneration in three groups. Extraction alveoli were treated with either a collagen cone and membrane (test group), xenogenic graft and membrane (positive control), or left untreated (negative control). Bone samples were collected at 4 and 12 weeks post-surgery. Tissue sections were stained with Masson Goldner trichrome for histomorphometric analysis. X-ray imaging was used to assess bone atrophy and density. Bone texture was evaluated by examining spongious structures in the mandibular region. Quantitative analysis focused on bone marrow volume and osteoid formation. The study design allowed for longitudinal comparison of healing outcomes. Data collection included both qualitative and quantitative measures of bone regeneration.

After 12 weeks, the test group showed 37.6% bone atrophy compared to untreated alveoli (P=0.002). The positive control group had 32% reduced atrophy (P=0.046). All groups exhibited nearly complete osseous organization by 12 weeks. Histomorphometric analysis revealed higher bone marrow levels in test and negative controls than in the positive control. No significant differences were found in bone tissue or osteoid quantification. X-ray analysis confirmed reduced resorption in the test group compared to untreated alveoli. Bone texture in the mandibular region showed typical spongious structures. The collagen-based product supported natural bone regeneration without altering texture. These findings suggest collagen-based augmentation is effective in reducing bone loss.

The authors concluded that collagen-based augmentation reduces bone resorption compared to untreated alveoli. The resulting bone structure was similar to natural regeneration. No significant differences were found in bone tissue composition between groups. The collagen product showed advantages over xenogenic materials in bone density and texture. These findings suggest collagen-based products are viable for socket augmentation. The study supports the use of pure collagen for bone regeneration without foreign body reactions. Researchers propose that collagen-based augmentation may be preferable to xenogenic grafts. The results indicate collagen can effectively support osseous healing while maintaining natural bone structure.